Doctors from the Cleveland Clinic talk about how this new non-opioid pain medication could help reduce the issue of opioid ...

( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...

The FDA has approved Vertex Pharmaceuticals’ Journavx, a new pain medication designed to reduce the risk of addiction and overdose associated with opioids. Intended for short-term pain after surgeries ...

Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...

The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.

Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...

All three cannabinoids reduced the electrical activity linked to Nav1.8, but CBG had the strongest effect. This suggests that CBG could be the most promising candidate for developing new pain ...

The Food and Drug Administration has approved a first of its kind prescription pain medication that is non-opioid.

People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...

A new non-opioid painkiller, JournaVX, has received approval from the FDA, marking the first new type of pain medication in ...

Emily Hernandez, a Missouri woman pardoned after her ties to the Jan. 6, 2021, insurrection at the U.S. Capitol, was ...

The FDA just approved a new pain medication called Journavx, which promises to treat pain without the risk of developing an addiction. 21 News is joined by Dr. Jianguo Cheng with the Cleveland Clinic ...